Thus, the low expression of LGALS9 in tumor tissues from patients with SCC might weakly interact with TIM-3 expressed on CIKs and finally facilitate CIK treatment efficacy in patients with SCC. The gene discussed is HAVCR2; the disease is neoplasm.